BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34853112)

  • 1. Models for predicting venous thromboembolism in ambulatory patients with lung cancer: a systematic review protocol.
    Yan AR; Samarawickrema I; Naunton M; Peterson GM; Yip D; Mortazavi R
    BMJ Open; 2021 Dec; 11(12):e055322. PubMed ID: 34853112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction models for venous thromboembolism in ambulatory adults with pancreatic and gastro-oesophageal cancer: protocol for systematic review and meta-analysis.
    Zaheer A; Naumovski N; Toohey K; Niyonsenga T; Yip D; Brown N; Mortazavi R
    BMJ Open; 2022 Mar; 12(3):e056431. PubMed ID: 35246422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thromboembolism in patients undergoing gastric cancer surgery: protocol for a systematic review and meta-analysis.
    Wang D; Yu Y; Tao P; Wang D; Chen Y; Chen H
    BMJ Open; 2020 Jan; 10(1):e033267. PubMed ID: 31919125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Schulman S; Couturaud F; Prandoni P; Eichinger S; Becattini C; Agnelli G; Büller HR; Brighton TA; Palareti G; Pinede L; Sabri E; Hutton B; Wells GA; Rodger MA;
    BMJ Open; 2017 Sep; 7(9):16950. PubMed ID: 28939565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic prediction models for oropharyngeal squamous cell carcinoma (OPSCC): a protocol for systematic review, critical appraisal and meta-analysis.
    Lu Z; Zhou X; Fu L; Li Y; Tian T; Liu Q; Zou H
    BMJ Open; 2023 Oct; 13(10):e073375. PubMed ID: 37827742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.
    Ensor J; Riley RD; Jowett S; Monahan M; Snell KIe; Bayliss S; Moore D; Fitzmaurice D;
    Health Technol Assess; 2016 Feb; 20(12):i-xxxiii, 1-190. PubMed ID: 26879848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
    Aikens GB; Rivey MP; Hansen CJ
    Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.
    Fuentes HE; Oramas DM; Paz LH; Casanegra AI; Mansfield AS; Tafur AJ
    Thromb Res; 2017 Jun; 154():28-34. PubMed ID: 28402864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE.
    Ensor J; Riley RD; Moore D; Bayliss S; Jowett S; Fitzmaurice DA
    Syst Rev; 2013 Oct; 2():91. PubMed ID: 24089702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review of prognostic models for recurrent venous thromboembolism (VTE) post-treatment of first unprovoked VTE.
    Ensor J; Riley RD; Moore D; Snell KI; Bayliss S; Fitzmaurice D
    BMJ Open; 2016 May; 6(5):e011190. PubMed ID: 27154483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of venous thromboembolism in people with active tuberculosis: a systematic review and meta-analysis protocol.
    Awana PA; Danwang C; Tochie JN; Bigna JJ
    BMJ Open; 2019 Nov; 9(11):e031402. PubMed ID: 31722945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
    Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
    Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models for predicting venous thromboembolism in ambulatory patients with lung cancer: A systematic review and meta-analysis.
    Yan AR; Samarawickrema I; Naunton M; Peterson GM; Yip D; Newman P; Mortazavi R
    Thromb Res; 2024 Feb; 234():120-133. PubMed ID: 38215613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Otten HM; Rutjes AW
    Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction models for acute kidney injury in critically ill patients: a protocol for systematic review and critical appraisal.
    Wang D; Zhang W; Luo J; Fang H; Jing S; Mei Z
    BMJ Open; 2021 May; 11(5):e046274. PubMed ID: 34011595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction models for recurrence and bleeding in patients with venous thromboembolism: A systematic review and critical appraisal.
    de Winter MA; van Es N; Büller HR; Visseren FLJ; Nijkeuter M
    Thromb Res; 2021 Mar; 199():85-96. PubMed ID: 33485094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of novel oral anticoagulants for the treatment of cancer-associated venous thromboembolism: protocol for an umbrella review of systematic reviews and meta-analyses.
    Xia Y; Tang L; Hu Y
    BMJ Open; 2023 Apr; 13(4):e066853. PubMed ID: 37024258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.